Groetelaars served as President, CEO and a Board member at
Hillrom from May 2018 until the company’s acquisition by Baxter
International, Inc., in December 2021. At Hillrom, Groetelaars led a
transformation of the business, successfully articulating and launching a
new connected-care strategy and vision, growing the portfolio through
seven acquisitions and one divestiture, and driving record financial
performance.
The Board has initiated a
search to identify the Company’s next CEO and has retained a
leading executive search firm to support the process.
Dentsply Sirona also announced the appointment of Barbara
Bodem as Interim Chief Financial Officer, effective upon Jorge Gomez’s
previously announced departure on May 6, 2022.
Bodem will join the
Company on April 25, 2022 and work closely with Gomez to ensure a
seamless transition.
Bodem is an accomplished executive with over two decades of financial leadership experience in the healthcare industry, most recently serving as Senior Vice President and CFO of Hillrom. Previously, Bodem served in senior leadership roles at Mallinckrodt Pharmaceuticals, Hospira and Eli Lilly and Company.
For more information, visit
Dentsplysirona.com